Agilent Reports First-Quarter Fiscal Year 2025 Financial Results

Original from: Agilent

First-quarter fiscal year 2025 

· Revenue of $1.68 billion for the first quarter ended Jan. 31, 2025, representing growth of 1.4% reported and up 1.2% on a core(1) basis compared with the first quarter of 2024.

· GAAP net income of $318 million; earnings per share (EPS) of $1.11, down 6% from the first quarter of 2024.

· Non-GAAP(2) net income of $377 million; EPS of $1.31, up 2% from the first quarter of 2024.

Outlook for full 2025 fiscal year and Q2

· Full-year revenue outlook is now in the range of $6.68 billion to $6.76 billion, representing a range of up 2.6% to 3.8% reported and 2.5% to 3.5% core(1). Non-GAAP EPS(3) is expected in the range of $5.54 to $5.61 per share.

· Q2 revenue outlook is expected to be in the range of $1.61 billion to $1.65 billion, an increase of 2.4% to 4.9% reported and up 2.5% to 5.0% core(1). Non-GAAP EPS(3) is expected in the range of $1.25 to $1.28 per share

Agilent Technologies Inc. (NYSE: A) today reported revenue of $1.68 billion for the first quarter ended Jan. 31, 2025, representing growth of 1.4% reported and up 1.2% core(1) compared to the first quarter of 2024.

First-quarter GAAP net income was $318 million, or $1.11 per share. This compares with $348 million, or $1.18 per share, in the first quarter of fiscal year 2024. Non-GAAP(2) net income was $377 million, or $1.31 per share during the quarter, compared with $380 million or $1.29 per share during the year-ago quarter.

"The Agilent team delivered better than our expectations in Q1. As a result of a solid start to the year, we're maintaining our core growth and EPS expectations for the year," said Agilent President and CEO Padraig McDonnell. "We have moved from planning to execution on our market-first strategy we introduced at our Analyst and Investor Day and are seeing the early benefits of our Ignite Transformation to become nimbler and make decisions faster in service to our customers."

Financial Highlights

In the first quarter of 2025, Agilent implemented certain changes to its segment reporting structure. Prior period segment information has been recast to reflect these changes. These changes have no impact on Agilent's consolidated financial statements.

Life Sciences and Diagnostics Markets Group
Agilent's Life Sciences and Diagnostics Markets Group (LDG) reported first-quarter revenue of $647 million, an increase of 4% reported and 1% core(1) year-over-year. LDG's operating margin for the quarter was 18.1%.

Agilent CrossLab Group
The Agilent CrossLab Group (ACG) reported first-quarter revenue of $696 million, an increase of 1% reported and 3% core(1) year-over-year. ACG's operating margin for the quarter was 31.8%.

Applied Markets Group
The Applied Markets Group (AMG) reported first-quarter revenue of $338 million, a decrease of 4% reported and 2% core(1) year-over-year. AMG's operating margin for the quarter was 25.0%.

Full Year 2025 and Second-Quarter Outlook

Full-year revenue outlook is now in the range of $6.68 billion to $6.76 billion, representing growth of 2.6% to 3.8% reported, while maintaining growth of 2.5% to 3.5% core(1). Non-GAAP EPS(3) is still expected in the range of $5.54 to $5.61 per share.

The outlook for second-quarter revenue is expected to be in the range of $1.61 billion to $1.65 billion, representing growth of 2.4% to 4.9% reported and up 2.5% to 5.0% core(1). Non-GAAP EPS(3) is expected in the range of $1.25 to $1.28 per share.

The outlook is based on forecasted currency exchange rates.

Source: Agilent Reports First-Quarter Fiscal Year 2025 Financial Results